Enhancing HIV Testing Services Through Community Pharmacies in Nigeria

By Staff Writer

August 28, 2024

Introduction

Human immunodeficiency virus (HIV) testing is a critical step in achieving the United Nations’ 90-90-90 goals, which aim to end acquired immunodeficiency syndrome (AIDS) by 2030. The World Health Organization (WHO) and UNAIDS have emphasised the importance of accessible HIV testing services (HTS). In Nigeria, a country with one of the highest HIV infection rates globally, community pharmacies have been identified as a key player in expanding these services. Researchers looked into the implementation strategies and outcomes of HIV testing in community pharmacies in Oyo State, Nigeria.

Community Pharmacists: The Frontline Healthcare Providers

Community pharmacies are uniquely positioned to provide healthcare services due to their accessibility and the trust they have built within their communities. These pharmacies offer a range of services, including health promotion, point-of-care testing, and medication management. In Nigeria, community pharmacists have demonstrated their ability to deliver primary healthcare services, including HIV testing. Community pharmacists underwent training to equip them with the necessary skills to conduct HIV tests and provide pre- and post-test counselling. Continuous supervision and support were provided to ensure adherence to the testing protocols. Ensuring the availability of testing materials and resources was crucial for the smooth operation of the services.

Implementation Strategies for HIV Testing Services

Effective implementation strategies are crucial for the success of any healthcare intervention. These strategies enhance the adoption, implementation, and sustainability of services. In this context, implementation outcomes such as penetration, adoption, acceptability, feasibility, fidelity, and appropriateness are essential. Measuring penetration evaluates the integration level of a service within a community. When stakeholders decide to use an innovation for the first time, we call it adoption. Acceptability is a measure of stakeholders’ reception of the service. Feasibility examines the service’s practicality. Fidelity ensures the service delivery aligns with the original intention.  Appropriateness evaluates the relevance of the service for the community.

Measuring Implementation Outcomes

In Oyo State, Nigeria, a study was conducted to measure the implementation outcomes of HIV testing services in community pharmacies. The study observed a high participation rate, with 90% of trained pharmacists providing HIV testing services. This high penetration rate is similar to other studies conducted globally. Factors like adequate training, pharmacist commitment, and supportive supervision influenced the service’s adoption. Clients showed high acceptability, with 77% willing to join the HIV screening. The implementation affirmed feasibility, as it encountered no major challenges. The measure of fidelity was the pharmacists’ ability to deliver the service as intended, although not all strictly adhered to the protocol. 

Figure 1. Delivery of HTS by community pharmacists from August to November 2019.

The Impact of Community Pharmacists on HIV Testing

Community pharmacists play a crucial role in providing accessible and confidential HIV testing services. Therefore, their involvement reduces the stigma associated with HIV testing and improves healthcare accessibility. The study found that pharmacists felt fulfilled and satisfied with offering HIV testing services. Clients appreciated the convenience and confidentiality of pharmacy-based testing. Previous studies confirm the ideal position of community pharmacists for providing HIV testing and other primary healthcare services. 

Conclusion

Community pharmacies in Nigeria have shown great potential in delivering HIV testing services. The high penetration and adoption rates indicate that pharmacists are willing and capable of providing these services. The study’s findings highlight the importance of effective implementation strategies and support the integration of HIV testing into community pharmacy practice. However, challenges such as resource availability and pharmacist remuneration need to be addressed to ensure the sustainability of the service. Policymakers should consider including HIV testing in the community pharmacy curriculum and providing the necessary support to pharmacists. By leveraging the accessibility and trust of community pharmacies, Nigeria can make significant strides towards achieving the UN’s goal of ending AIDS by 2030.

Reference url

Recent Posts

lenacapavir HIV PrEP access
    

Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prevention

💉 How can we ensure equitable access to HIV prevention methods like lenacapavir?

A recent initiative from the Global Fund, supported by key global health organizations, aims to provide affordable access to this new HIV pre-exposure prophylaxis medication.

With a goal to reach 2 million individuals over three years, this coordinated effort seeks to drastically cut HIV infections and align with our commitment to ending AIDS by 2030.

Explore the details of this impactful collaboration and how it could transform HIV prevention.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess

antimicrobial resistance africa
     

Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak

🌍 Are we prepared to tackle the hidden pandemic of antimicrobial resistance (AMR) in Africa?

With AMR rapidly becoming a dominant health crisis, it’s critical to understand its impact on our healthcare systems and most vulnerable populations.

The Africa CDC highlights the urgent need for substantial investment and coordinated responses to combat this escalating threat, alongside the ongoing Mpox outbreak.

Discover the pressing challenges and potential solutions in our latest article.

#SyenzaNews #GlobalHealth #HealthcareInnovation #AntimicrobialResistance #PublicHealth

BioSapien cancer drug delivery
    

BioSapien Innovative Cancer Drug Delivery Solutions

🌟 How is innovation in drug delivery shaping the future of cancer treatment? 🌟

Discover how UAE-based BioSapien is transforming the healthcare landscape with the MediChip™ platform, securing $5.5 million in pre-Series A funding to enhance cancer care.

This innovative solution promises to minimise side effects and improve treatment outcomes for patients, fully embracing the potential of biotechnology in the fight against cancer.

Read more about BioSapien’s journey and its impact on global health!

#SyenzaNews #biotechnology #oncology #innovation #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.